Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Arcturus Therapeutics Holdings Inc.ARCT · Entity 5523 | See Remarks | December 15, 2023 | December 19, 2023 |
| Arcturus Therapeutics Ltd.ARCT · Entity 160417 | Vice President of Finance | February 07, 2019 | February 11, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Arcturus Therapeutics Holdings Inc.
Report date December 15, 2023 · Filed December 19, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $28.88 · Expires 2033-12-15 | Direct | 30,000 |
Reported balance
After 2023-12-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-12-15 · Grant · Acquired 30,000 · Balance 30,000 F1: Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. F2: The shares underlying this option vest 25% on December 15, 2024, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended.
F2: The shares underlying this option vest 25% on December 15, 2024, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months.
Arcturus Therapeutics Ltd.
Report date February 07, 2019 · Filed February 11, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Incentive Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.99 · Expires 2029-02-06 | Direct | 10,000 |
Reported balance
After 2019-02-07 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-02-07 · Grant · Acquired 10,000 · Balance 10,000 F1: Vesting over a period of four years from Vest Base Date, with 25% of the options vesting on the first anniversary thereof and the remainder vesting in equal monthly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Vesting over a period of four years from Vest Base Date, with 25% of the options vesting on the first anniversary thereof and the remainder vesting in equal monthly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 15, 2023 Filed Dec 19, 2023 20:00 UTC | Arcturus Therapeutics Holdings Inc. ARCT · Entity 5523 | GrantEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $28.88 | $0.00 |
DisclosureSEC source: 0001193805-23-001627 · e619134_4-kummerfeld.xml · derivative · entry 1 Kummerfeld Keith C · CIK 0001762749 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2033-12-15 F1 · shares: Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. F2 · derivative.exercise_date: The shares underlying this option vest 25% on December 15, 2024, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months. Read SEC document |
| July 14, 2023 Filed Jul 18, 2023 18:50 UTC | Arcturus Therapeutics Holdings Inc. ARCT · Entity 5523 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,031 | $0.00 Strike: $14.12 | $0.00 |
DisclosureSEC source: 0001193805-23-001002 · e618788_4-kummerfeld.xml · derivative · entry 7 Kummerfeld Keith C · CIK 0001762749 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,938 Underlying: Common Stock · 1,031 shares Expires 2030-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the shares underlying the options vest on the one year anniversary of the date of grant, with the remainder vesting in 36 successive equal monthly increments thereafter. Read SEC document |
| July 14, 2023 Filed Jul 18, 2023 18:50 UTC | Arcturus Therapeutics Holdings Inc. ARCT · Entity 5523 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,437 | $0.00 Strike: $4.99 | $0.00 |
DisclosureSEC source: 0001193805-23-001002 · e618788_4-kummerfeld.xml · derivative · entry 6 Kummerfeld Keith C · CIK 0001762749 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,126 Underlying: Common Stock · 1,437 shares Expires 2029-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the shares underlying the options vest on the one year anniversary of the date of grant, with the remainder vesting in 36 successive equal monthly increments thereafter. Read SEC document |
| July 14, 2023 Filed Jul 18, 2023 18:50 UTC | Arcturus Therapeutics Holdings Inc. ARCT · Entity 5523 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,500 | $0.00 Strike: $9.04 | $0.00 |
DisclosureSEC source: 0001193805-23-001002 · e618788_4-kummerfeld.xml · derivative · entry 5 Kummerfeld Keith C · CIK 0001762749 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 4,500 shares Expires 2028-07-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the shares underlying the options vest on the one year anniversary of the date of grant, with the remainder vesting in 36 successive equal monthly increments thereafter. Read SEC document |
| July 14, 2023 Filed Jul 18, 2023 18:50 UTC | Arcturus Therapeutics Holdings Inc. ARCT · Entity 5523 | SaleCommon Stock | 6,968 | $35.00 | $243,880.00 |
DisclosureSEC source: 0001193805-23-001002 · e618788_4-kummerfeld.xml · nonDerivative · entry 4 Kummerfeld Keith C · CIK 0001762749 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 950 F1 · shares: Represents shares sold pursuant to the Reporting Person's written trading plan pursuant to Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: These shares were sold in multiple transactions, each at a price of $35.00 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by it on July 14, 2023. Read SEC document |
| July 14, 2023 Filed Jul 18, 2023 18:50 UTC | Arcturus Therapeutics Holdings Inc. ARCT · Entity 5523 | Exercise / conversionCommon Stock | 1,031 | $14.12 | $14,557.72 |
DisclosureSEC source: 0001193805-23-001002 · e618788_4-kummerfeld.xml · nonDerivative · entry 3 Kummerfeld Keith C · CIK 0001762749 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,918 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 14, 2023 Filed Jul 18, 2023 18:50 UTC | Arcturus Therapeutics Holdings Inc. ARCT · Entity 5523 | Exercise / conversionCommon Stock | 1,437 | $4.99 | $7,170.63 |
DisclosureSEC source: 0001193805-23-001002 · e618788_4-kummerfeld.xml · nonDerivative · entry 2 Kummerfeld Keith C · CIK 0001762749 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,887 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 14, 2023 Filed Jul 18, 2023 18:50 UTC | Arcturus Therapeutics Holdings Inc. ARCT · Entity 5523 | Exercise / conversionCommon Stock | 4,500 | $9.04 | $40,680.00 |
DisclosureSEC source: 0001193805-23-001002 · e618788_4-kummerfeld.xml · nonDerivative · entry 1 Kummerfeld Keith C · CIK 0001762749 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,450 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 18, 2023 Filed Apr 19, 2023 16:57 UTC | Arcturus Therapeutics Holdings Inc. ARCT · Entity 5523 | SaleCommon Stock | 6,968 | $28.18 | $196,358.24 |
DisclosureSEC source: 0001193805-23-000578 · e618515_4-kummerfeld.xml · nonDerivative · entry 4 Kummerfeld Keith C · CIK 0001762749 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 950 F1 · shares: Represents shares sold pursuant to the Reporting Person's written trading plan pursuant to Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.62 to $28.57 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by it at each separate price on April 17, 2023. Read SEC document |
| April 18, 2023 Filed Apr 19, 2023 16:57 UTC | Arcturus Therapeutics Holdings Inc. ARCT · Entity 5523 | Exercise / conversionCommon Stock | 1,437 | $4.99 | $7,170.63 |
DisclosureSEC source: 0001193805-23-000578 · e618515_4-kummerfeld.xml · nonDerivative · entry 3 Kummerfeld Keith C · CIK 0001762749 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,918 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 18, 2023 Filed Apr 19, 2023 16:57 UTC | Arcturus Therapeutics Holdings Inc. ARCT · Entity 5523 | Exercise / conversionCommon Stock | 4,500 | $9.04 | $40,680.00 |
DisclosureSEC source: 0001193805-23-000578 · e618515_4-kummerfeld.xml · nonDerivative · entry 2 Kummerfeld Keith C · CIK 0001762749 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,481 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 18, 2023 Filed Apr 19, 2023 16:57 UTC | Arcturus Therapeutics Holdings Inc. ARCT · Entity 5523 | Exercise / conversionCommon Stock | 1,031 | $14.12 | $14,557.72 |
DisclosureSEC source: 0001193805-23-000578 · e618515_4-kummerfeld.xml · nonDerivative · entry 1 Kummerfeld Keith C · CIK 0001762749 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,981 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 17, 2023 Filed Apr 19, 2023 16:57 UTC | Arcturus Therapeutics Holdings Inc. ARCT · Entity 5523 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,437 | $0.00 Strike: $4.99 | $0.00 |
DisclosureSEC source: 0001193805-23-000578 · e618515_4-kummerfeld.xml · derivative · entry 7 Kummerfeld Keith C · CIK 0001762749 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,563 Underlying: Common Stock · 1,437 shares Expires 2029-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the shares underlying the options vest on the one year anniversary of the date of grant, with the remainder vesting in 36 successive equal monthly increments thereafter. Read SEC document |
| April 17, 2023 Filed Apr 19, 2023 16:57 UTC | Arcturus Therapeutics Holdings Inc. ARCT · Entity 5523 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,500 | $0.00 Strike: $9.04 | $0.00 |
DisclosureSEC source: 0001193805-23-000578 · e618515_4-kummerfeld.xml · derivative · entry 6 Kummerfeld Keith C · CIK 0001762749 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,500 Underlying: Common Stock · 4,500 shares Expires 2028-07-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the shares underlying the options vest on the one year anniversary of the date of grant, with the remainder vesting in 36 successive equal monthly increments thereafter. Read SEC document |
| April 17, 2023 Filed Apr 19, 2023 16:57 UTC | Arcturus Therapeutics Holdings Inc. ARCT · Entity 5523 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,031 | $0.00 Strike: $14.12 | $0.00 |
DisclosureSEC source: 0001193805-23-000578 · e618515_4-kummerfeld.xml · derivative · entry 5 Kummerfeld Keith C · CIK 0001762749 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,969 Underlying: Common Stock · 1,031 shares Expires 2030-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the shares underlying the options vest on the one year anniversary of the date of grant, with the remainder vesting in 36 successive equal monthly increments thereafter. Read SEC document |
| December 09, 2022 Filed Dec 16, 2022 18:28 UTC | Arcturus Therapeutics Holdings Inc. ARCT · Entity 5523 | GrantEmployee Stock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $16.92 | $0.00 |
DisclosureSEC source: 0001193805-22-001746 · e618136_4-kummerfeld.xml · derivative · entry 1 Kummerfeld Keith C · CIK 0001762749 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2032-12-09 F1 · shares: Represents options to purchase shares of common stock approved by the Board of Directors on December 9, 2022 pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. F2 · derivative.exercise_date: The shares underlying this option vest 25% on December 9, 2023, the first anniversary of the date this award was approved by the Board of Directors, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months. Read SEC document |
| June 21, 2022 Filed Jun 23, 2022 16:17 UTC | Arcturus Therapeutics Holdings Inc. ARCT · Entity 5523 | GrantEmployee Stock Option (right to buy) · Derivative | 33,000 | $0.00 Strike: $34.57 | $0.00 |
DisclosureSEC source: 0001193805-22-001003 · e621776_4-kummerfeld.xml · derivative · entry 1 Kummerfeld Keith C · CIK 0001762749 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,000 Underlying: Common Stock · 33,000 shares Expires 2031-12-10 F1 · shares: Represents options to purchase shares of common stock conditionally approved by the Board of Directors on December 10, 2021, subject to approval of an amendment to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan by the Company's stockholders, which approval was obtained at the Company's 2022 Annual Meeting of Stockholders held on June 21, 2022. F2 · derivative.exercise_date: The shares underlying this option vest 25% on December 10, 2022, the first anniversary of the date this award was conditionally approved by the Board of Directors, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 19:41 UTC | Arcturus Therapeutics Holdings Inc. ARCT · Entity 5523 | GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $99.29 | $0.00 |
DisclosureSEC source: 0001193805-20-001611 · e620165_4-kummerfeld.xml · derivative · entry 1 Kummerfeld Keith C · CIK 0001762749 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2030-12-18 F1 · derivative.exercise_date: 25% of the shares underlying the option vest on the one year anniversary of the date of grant, with the remainder vesting in 36 successive equal monthly increments thereafter. Read SEC document |
| June 12, 2020 Filed Jun 12, 2020 18:22 UTC | Arcturus Therapeutics Holdings Inc. ARCT · Entity 5523 | PurchaseCommon Stock | 450 | $33.33 | $14,998.50 |
DisclosureSEC source: 0000899243-20-016410 · doc4.xml · nonDerivative · entry 1 Kummerfeld Keith C · CIK 0001762749 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 950 Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 20:06 UTC | Arcturus Therapeutics Holdings Inc. ARCT · Entity 5523 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $14.12 | $0.00 |
DisclosureSEC source: 0000899243-20-005387 · doc4.xml · derivative · entry 1 Kummerfeld Keith C · CIK 0001762749 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-02-18 F1 · derivative.exercise_date: 25% of the shares underlying the option vest on the one year anniversary of the date of grant, with the remainder vesting in 36 successive equal monthly increments thereafter. Read SEC document |
| September 12, 2019 Filed Sep 12, 2019 21:00 UTC | Arcturus Therapeutics Holdings Inc. ARCT · Entity 5523 | PurchaseCommon Stock | 500 | $10.69 | $5,346.70 |
DisclosureSEC source: 0000899243-19-023531 · doc4.xml · nonDerivative · entry 1 Kummerfeld Keith C · CIK 0001762749 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Read SEC document |
| February 07, 2019 Filed Feb 11, 2019 16:21 UTC | Arcturus Therapeutics Ltd. ARCT · Entity 160417 | GrantIncentive Stock Option (right to buy) · Derivative | 10,000 | $4.99 Strike: $4.99 | $49,900.00 |
DisclosureSEC source: 0001566049-19-000005 · edgardoc.xml · derivative · entry 1 Kummerfeld Keith C · CIK 0001762749 · Vice President of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-02-06 F1 · derivative.exercise_date: Vesting over a period of four years from Vest Base Date, with 25% of the options vesting on the first anniversary thereof and the remainder vesting in equal monthly installments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.